Insider Trading › ELV › Insiders
Elevance Health, Inc.
ELV·NYSE·
United States·Insider activity
United States·Insider activity$400.09
+5.58 (+1.41%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
ELV
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
ELVS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
In the last 180 days, ELV insiders filed 3 purchases ($1.4M) and 3 sales ($827K) on the open market, by 4 insiders. Newest filing Jul 17, 2026 (2 months ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by ELV insiders · Form 4 · last two years
On Record
$1.4MPurchases · 180 days
$827KSales · 180 days
46Open-market transactions on record
4Insiders filing · 180 days
Purchases (code P) and sales (code S) of ELV common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
46 on record · newest trade first
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| BOUDREAUX GAILPresident and CEO · Director | Purchase | +680 | $366.41 | $249K | 169.9Kdirect | Jul 17, 2026 | Jul 17, 2026 | Form 4 ↗ |
| BOUDREAUX GAILPresident and CEO · Director | Purchase | +2,045 | $368.25 | $753K | 172.0Kdirect | Jul 17, 2026 | Jul 17, 2026 | Form 4 ↗ |
| PERU RAMIRO GDirector · Director | Purchase | +1,000 | $366.05 | $366K | 10.9Kdirect | Jul 17, 2026 | Jul 17, 2026 | Form 4 ↗ |
| Penczek Ronald WCAO & Controller | Sale | −369 | $403.16 | $149K | 3,740direct | Jun 12, 2026 | Jun 15, 2026 | Form 4 ↗ |
| Dixon Robert L JRDirector | Sale | −151 | $401.77 | $61K | 10.7Kdirect | Jun 11, 2026 | Jun 12, 2026 | Form 4 ↗ |
| Penczek Ronald WCAO & Controller | Sale | −1,531 | $403.13 | $617K | 4,109direct | May 19, 2026 | May 20, 2026 | Form 4 ↗ |
| SCHULMAN AMY WDirector | Sale | −26 | $287.50 | $7K | 218direct | Mar 12, 2026 | Mar 23, 2026 | Form 4 ↗ |
| Kendrick Charles Morgan JREVP & President, Commercial | Sale | −3,196 | $284.92 | $911K | 11.8Kdirect | Mar 6, 2026 | Mar 9, 2026 | Form 4 ↗ |
| COLLIS STEVEN HDirector | Purchase | +3,000 | $289.84 | $870K | 3,639direct | Mar 5, 2026 | Mar 6, 2026 | Form 4 ↗ |
| DeVore Susan D.Director | Purchase | +1,200 | $312.15 | $375K | 3,502direct | Aug 19, 2025 | Aug 21, 2025 | Form 4 ↗ |
| BOUDREAUX GAILPresident and CEO · Director | Purchase | +1,050 | $287.96 | $302K | 151.0Kdirect | Jul 18, 2025 | Jul 18, 2025 | Form 4 ↗ |
| BOUDREAUX GAILPresident and CEO · Director | Purchase | +5,116 | $287.12 | $1.5M | 150.0Kdirect | Jul 18, 2025 | Jul 18, 2025 | Form 4 ↗ |
| BOUDREAUX GAILPresident and CEO · Director | Purchase | +2,334 | $286.07 | $668K | 144.9Kdirect | Jul 18, 2025 | Jul 18, 2025 | Form 4 ↗ |
| Kaye MarkEVP & CFO | Sale | −4,588 | $424.82 | $1.9M | 19.0Kdirect | Apr 24, 2025 | Apr 25, 2025 | Form 4 ↗ |
| Penczek Ronald WCAO & Controller | Sale | −443 | $415.13 | $184K | 1,847direct | Mar 10, 2025 | Mar 11, 2025 | Form 4 ↗ |
| Kendrick Charles Morgan JREVP & President, Commercial | Sale | −3,504 | $396.30 | $1.4M | 10.1Kdirect | Mar 5, 2025 | Mar 5, 2025 | Form 4 ↗ |
| Kendrick Charles Morgan JREVP & President, Commercial | Sale | −7,417 | $432.14 | $3.2M | 8,423direct | Oct 18, 2024 | Oct 18, 2024 | Form 4 ↗ |
| PERU RAMIRO GDirector | Sale | −753 | $531.52 | $400K | 8,744direct | Aug 5, 2024 | Aug 6, 2024 | Form 4 ↗ |
| BOUDREAUX GAILPresident and CEO · Director | Sale | −2,250 | $504.27 | $1.1M | 126.7Kdirect | Jul 22, 2024 | Jul 23, 2024 | Form 4 ↗ |
| BOUDREAUX GAILPresident and CEO · Director | Sale | −1,000 | $503.67 | $504K | 129.0Kdirect | Jul 22, 2024 | Jul 23, 2024 | Form 4 ↗ |
| BOUDREAUX GAILPresident and CEO · Director | Sale | −2,250 | $502.23 | $1.1M | 130.0Kdirect | Jul 22, 2024 | Jul 23, 2024 | Form 4 ↗ |
| BOUDREAUX GAILPresident and CEO · Director | Sale | −6,621 | $501.40 | $3.3M | 132.2Kdirect | Jul 22, 2024 | Jul 23, 2024 | Form 4 ↗ |
| BOUDREAUX GAILPresident and CEO · Director | Sale | −20.8K | $500.36 | $10.4M | 138.8Kdirect | Jul 22, 2024 | Jul 23, 2024 | Form 4 ↗ |
| BOUDREAUX GAILPresident and CEO · Director | Sale | −1,100 | $498.50 | $548K | 159.6Kdirect | Jul 22, 2024 | Jul 23, 2024 | Form 4 ↗ |
| Dixon Robert L JRDirector | Sale | −305 | $506.76 | $155K | 9,721direct | Jul 19, 2024 | Jul 22, 2024 | Form 4 ↗ |
| Norwood Felicia FEVP & President,Gov Health Ben | Sale | −3,434 | $532.68 | $1.8M | 27.3Kdirect | Apr 24, 2024 | Apr 25, 2024 | Form 4 ↗ |
| Norwood Felicia FEVP & President,Gov Health Ben | Sale | −2,765 | $532.14 | $1.5M | 30.7Kdirect | Apr 24, 2024 | Apr 25, 2024 | Form 4 ↗ |
| Norwood Felicia FEVP & President,Gov Health Ben | Sale | −100 | $534.74 | $53K | 31.5Kdirect | Apr 23, 2024 | Apr 25, 2024 | Form 4 ↗ |
| Norwood Felicia FEVP & President,Gov Health Ben | Sale | −14.0K | $533.73 | $7.5M | 31.6Kdirect | Apr 23, 2024 | Apr 25, 2024 | Form 4 ↗ |
| Kendrick Charles Morgan JREVP & President, Commercial | Sale | −2,432 | $500.46 | $1.2M | 15.8Kdirect | Mar 8, 2024 | Mar 12, 2024 | Form 4 ↗ |
| Penczek Ronald WCAO & Controller | Sale | −916 | $504.58 | $462K | 1,764direct | Mar 6, 2024 | Mar 8, 2024 | Form 4 ↗ |
| Haytaian Peter DEVP & Pres Carelon & CarelonRx | Sale | −15.0K | $500.18 | $7.5M | 18.9Kdirect | Mar 4, 2024 | Mar 5, 2024 | Form 4 ↗ |
| Haytaian Peter DEVP & Pres Carelon & CarelonRx | Sale | −1,889 | $500.18 | $945K | 33.9Kdirect | Mar 4, 2024 | Mar 5, 2024 | Form 4 ↗ |
| Haytaian Peter DEVP & Pres Carelon & CarelonRx | Sale | −4,206 | $500.18 | $2.1M | 35.8Kdirect | Mar 4, 2024 | Mar 5, 2024 | Form 4 ↗ |
| PERU RAMIRO GDirector | Sale | −753 | $500.00 | $377K | 9,109direct | Feb 7, 2024 | Feb 9, 2024 | Form 4 ↗ |
| Todt Blair WilliamsEVP, CLO & CAO | Sale | −5,492 | $484.02 | $2.7M | 12.5Kdirect | Dec 14, 2023 | Dec 15, 2023 | Form 4 ↗ |
| Penczek Ronald WCAO & Controller | Sale | −1,055 | $475.17 | $501K | 1,787direct | Nov 30, 2023 | Dec 1, 2023 | Form 4 ↗ |
| Penczek Ronald WCAO & Controller | Sale | −64 | $454.35 | $29K | 2,842direct | Oct 24, 2023 | Oct 26, 2023 | Form 4 ↗ |
| Dixon Robert L JRDirector | Sale | −310 | $476.71 | $148K | 9,638direct | Jul 21, 2023 | Jul 21, 2023 | Form 4 ↗ |
| MCCARTHY GLORIA MEVP & Chief Administrative Off | Sale | −3,625 | $446.06 | $1.6M | 51.4Kdirect | Mar 24, 2023 | Mar 27, 2023 | Form 4 ↗ |
| MCCARTHY GLORIA MEVP & Chief Administrative Off | Sale | −5,573 | $445.30 | $2.5M | 55.1Kdirect | Mar 24, 2023 | Mar 27, 2023 | Form 4 ↗ |
| MCCARTHY GLORIA MEVP & Chief Administrative Off | Sale | −3,000 | $444.33 | $1.3M | 60.6Kdirect | Mar 24, 2023 | Mar 27, 2023 | Form 4 ↗ |
| MCCARTHY GLORIA MEVP & Chief Administrative Off | Sale | −1,800 | $443.27 | $798K | 63.6Kdirect | Mar 24, 2023 | Mar 27, 2023 | Form 4 ↗ |
| MCCARTHY GLORIA MEVP & Chief Administrative Off | Sale | −500 | $442.02 | $221K | 65.4Kdirect | Mar 24, 2023 | Mar 27, 2023 | Form 4 ↗ |
| MCCARTHY GLORIA MEVP & Chief Administrative Off | Sale | −600 | $440.78 | $264K | 65.9Kdirect | Mar 24, 2023 | Mar 27, 2023 | Form 4 ↗ |
| Kendrick Charles Morgan JREVP & President, Commercial | Sale | −2,314 | $462.22 | $1.1M | 15.3Kdirect | Mar 9, 2023 | Mar 13, 2023 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →